Chinese drug discovery platform QureBio raised corporate funding last week while JD.com and Qi-Anxin Technology Group were among the LPs that helped set up the $470m Shoudu Pan Healthcare Industry Fund.
Funding
Indonesia-based coffeehouse chain operator Kopi Kenangan reached a $96m first close today for its series C funding featuring investors including internet company Kunlun. Investment firm Tybourne Capital Management led the tranche completed at a valuation above $1bn, investing alongside Horizons Ventures, B Capital and Falcon Edge Capital.
China-based drug discovery platform QureBio raised RMB200m ($31m) in a series B round on Thursday led by financial services firm Bank of Communications’ Bocom International unit. Oriza Holdings, Spinnotec, Longmen Capital and…
